Posted in | News | Lithium | Mining Business

Mosaic Minerals Acquires Lithium-Cesium-Rubidium Pegmatite Corridor in Northern Quebec

Mosaic Minerals Corporation (“Mosaic” or “The Company”) acquired by map staking and from two prospectors the Abrat SM project consisting of 148 cells with an area of ​​approximately 6,590 hectares located approximately 50 km east of the municipality of Kangiqsualujjuaq, in Nunavik, Quebec.

The Abrat SM project is located in a geological environment favorable to the presence of lithium.

Nearly 25 rock outcrops visited by the MERN demonstrate the potential presence of a NW-SE pegmatiferous corridor of nearly 20 kilometers. Five samples from outcrops located in this corridor were analyzed by the MERN and the results showed significant values ​​in lithium ranging from 162 to 359 ppm, in cesium (from 10 to 49 ppm) and in rubidium (from 95 to 443 ppm) over a distance of more than seven (7) km. This pegmatiferous corridor is mainly owned by the company Mosaic (148 cells) as well as by the private company Arlène Explorations (8 cells).

The presence of lanthanum as well as thorium, yttrium, cerium, molybdenum, and zinc are also noted in this corridor.

“The Abrat SM project adds to our portfolio which contains over 65,000 hectares of critical mineral potential. Mosaic is very well positioned in most active camps for lithium exploration, and we believe that Northern Quebec still holds great opportunities,” concluded Jonathan Hamel, President, and CEO of Mosaic Minerals.

Eighty claims were acquired from two prospectors in return for 270,000 common shares of the company and a 1% NSR royalty.

The technical content of this press release has been reviewed and approved by Mr. Gilles Laverdière, P.Geo., an independent consulting geologist and a Qualified Person as defined in NI 43-101.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.